Both in R&D — Physical & Biological Sciences
MaxCyte vs NRC Health
Over the past year MXCT returned +10.3% and NRC returned +77.1%; their daily moves had a correlation of 0.14.
MXCT +10.3% NRC +77.1%Growth of $1, one year, split-adjusted
| Metric | MXCT | NRC |
|---|---|---|
| Price | $1.71 | $23.47 |
| Market cap | $176.5M | $519.1M |
| Today | +11.04% | +7.91% |
| 1 month | +44.9% | +11.5% |
| 6 months | +109.1% | +41.9% |
| Year to date | +10.3% | +25.0% |
| 1 year | +11.0% | +105.5% |
| Revenue growth (YoY) | −14.5% | +4.0% |
| Gross margin | 77.0% | 61.7% |
| Net margin | −122.0% | −9.3% |
| P/E (TTM) | — | 93.5× |
| Price / sales | 5.7× | 3.7× |
| Net cash | $105.7M | -$86.7M |
| Dividend yield | — | 2.73% |
| Volatility (60d) | 78.8% | 45.5% |
| Short % of float | 2.0% | 7.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).